1-5 of 5
Marta Cremonesi
Close
Sort by
Journal Articles

Integration of Targeted Gene Expression Profiling and FDG-PET Radiomics Uncovers Radiometabolic Signatures Associated with Outcome in Diffuse Large B-Cell Lymphoma

Saveria Mazzara, Laura L. Travaini, Francesca Botta, Chiara Granata, Giovanna Motta, Federica Melle, Stefano Fiori, Valentina Tabanelli, Anna Vanazzi, Safaa M. Ramadan, Tommaso Radice, Sara Raimondi, Giuliana Lo Presti, Mahila E. Ferrari, Marta Cremonesi, Francesco Ceci, Corrado Tarella, Stefano A Pileri, Enrico Derenzini
Journal: Blood
Blood (2021) 138 (Supplement 1): 3496.
https://doi.org/10.1182/blood-2021-152679
Published: 2021
Journal Articles

Red Marrow Dosimetry and Stem Cell Reinfusion in High Dose 90 Y - Ibritumomab Tiuxetan.

Anna Vanazzi, Daniele Laszlo, Marta Cremonesi, Chiara Maria Grana, Stefano Papi, Alessandra Alietti, Sarah Jayne Liptrott, Liliana Calabrese, Giovanni Paganelli, Giovanni Martinelli
Journal: Blood
Blood (2008) 112 (11): 2187.
https://doi.org/10.1182/blood.V112.11.2187.2187
Published: 2008
Journal Articles

High Dose 90Yttrium Ibritumomab Tiuxetan with PBSC Support in Refractory-Resistant NHL Patients.

Anna Vanazzi, MD, Pier Francesco Ferrucci, MD, Chiara Grana, MD, Marta Cremonesi, MPh, Margherita Clerici, RN, Davide Radice, ST, Stefano Papi, PhD, Liliana Calabrese, DM, Giovanni Paganelli, MD, Giovanni Martinelli, MD
Journal: Blood
Blood (2007) 110 (11): 1890.
https://doi.org/10.1182/blood.V110.11.1890.1890
Published: 2007
Journal Articles

High Dose 90 Yttrium Ibritumomab Tiuxetan (Zevalin) with PBSC Support in Refractory-Resistant NHL Patients: A Phase I/II Study.

Anna Vanazzi, MD, Pier Francesco Ferrucci, MD, Chiara Grana, MD, Marta Cremonesi, MPH, Margherita Clerici, RN, Davide Radice, ST, STefano Papi, Liliana Calabrese, DM, Giovanni Paganelli, MD, Giovanni Martinelli, MD
Journal: Blood
Blood (2006) 108 (11): 2720.
https://doi.org/10.1182/blood.V108.11.2720.2720
Published: 2006
Journal Articles

High Dose Zevalin (90Yttrium Ibritumomab Tiuxetan) Treatment with PBSC Support in Refractory-Resistant NHL Patients: Preliminary Results of a Phase I/II Study.

Anna Vanazzi, MD, Pierfrancesco Ferrucci, MD, Mahila Ferrari, Liliana Calabrese, Marta Cremonesi, Mirco Bartolomei, MD, Giovanni Paganelli, MD, Giovanni Martinelli, MD
Journal: Blood
Blood (2005) 106 (11): 488.
https://doi.org/10.1182/blood.V106.11.488.488
Published: 2005